Upstream Bio raises $255 mln in US IPO
11/10/2024 24:41
Oct 10 (Reuters) - Upstream Bio UPB.O , which is developing treatments for some respiratory disorders, said on Thursday it had raised $255 million in its initial public offering in the United States. (Reporting by Gursimran Kaur and Arasu Kannagi Basil in Bengaluru; Editing by Alan Barona) ((GursimranKaur.Mehar@thomsonreuters.com))
Recent news on Upstream Bio
See all newsUpstream Bio Q2 net loss narrows slightly on lower R&D costs
Upstream Bio Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
Brief: Upstream Bio To Showcase Additional Efficacy Data From The Phase 2 Vibrant Trial Of Verekitug In Crswnp In Oral Session At Eaaci 2026
Upstream Bio Q1 net loss widens on higher R&D costs